内源性上腺素对心脏缩,纤维化和损伤的保护作用
Pei Niu1, Takayuki Shindo, Hiroshi Iwata
1Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Circulation
|February 18, 2004
概括
内源性上腺素 (AM) 保护心血管应激. 降低的AM水平通过增强ERK激活来加剧心脏缩和损伤,这表明AM是治疗标.
科学领域:
- 心血管生理学心血管生理学
- 分子生物学分子生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 阿德里诺米杜林 (AM) 是一种具有已知的血管扩展特性和潜在心血管作用的.
- 内源性AM在压力下的心血管调节中的作用仍然不清楚.
研究的目的:
- 研究内源性AM在心血管系统中的活性.
- 评估AM缺乏对心血管和脏应激反应的影响.
主要方法:
- 使用了AM-异合性淘汰 (AM+/-) 和野生型小鼠,接受了大动脉收缩或血管激素II输液.
- 分析了心脏缩标志物,基因表达,功能和细胞外信号调节激酶 (ERK) 激活.
- 研究了蛋白激酶C (PKC) 和蛋白激酶A (PKA) 途径的作用.
主要成果:
- 与野生类型对照相比,AM+/-小鼠表现出恶化的心脏缩,纤维化和损伤.
- 压力条件显著增加了心脏ERK激活,AM+/-小鼠的效果更为明显.
- 再组合AM治疗通过PKA-依赖的途径抑制了血管素II诱导的ERK激活.
结论:
- 内源性AM提供了对压力诱导的心脏缩的保护作用.
- 在AM的保护机制包括通过PKC和PKA通路调节ERK激活.
- 在心血管疾病中,AM是潜在的治疗点.
相关概念视频
Hormonal Regulation
37.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.2K
Antihypertensive Drugs: Action of β1 Blockers
2.3K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.3K
Heart Failure Drugs: Diuretics
1.2K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Hormonal Regulation of Blood Pressure
8.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
8.2K
Heart Failure II: Pathophysiology
1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K


